https://doctransparency.com/doctor/tx/amarillo/sean-milligan-1861438061
Medicare Enrolled

Dr. Sean Milligan, MD

Neurology · Amarillo, TX
Practice pattern: Mixed Practice— Diverse clinical practice across multiple procedure types
Speaking/Promotional
6700 W 9TH AVE, Amarillo, TX 79106
8063580200
In practice since 2006 (19 years)
NPI: 1861438061 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Milligan from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Milligan? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Milligan

Dr. Sean Milligan is a neurology in Amarillo, TX, with 19 years in practice. Based on federal Medicare data, Dr. Milligan performed 80,102 Medicare services across 2,177 unique beneficiaries.

Between the years covered by Open Payments, Dr. Milligan received a total of $644,874 from 64 pharmaceutical and/or device companies across 1745 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in neurology. The majority of payments are for speaking programs and promotional activities, reflecting participation in industry-sponsored events. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Milligan is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 19 years in practice▲ Top 1% volume in TX$ $644,874 industry payments

Medicare Practice Summary

Medicare Utilization ↗
80,102
Medicare services
Top 1% in TX for neurology
2,177
Unique beneficiaries
$15
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~4,216 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

ProcedureVolumeAvg. paidAvg. submitted
Injection, natalizumab, 1 mg46,201$18$43
Botox injection, per unit30,800$5$10
Office visit, established patient (30-39 min)760$87$230
Office visit, established patient (20-29 min)517$60$162
Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less288$44$145
Needle measurement of electrical activity in arm or leg muscles, complete study182$73$209
New patient office visit (45-59 min)155$104$350
Blood draw (venipuncture)145$8$13
Office visit, established patient, complex (40-54 min)114$127$310
Injection of chemical for paralysis of facial and neck nerve muscles on both sides of face105$105$300
Vitamin B-12 level test82$15$60
Office visit, established patient (10-19 min)79$37$95
Nerve conduction, 7-8 studies68$123$414
Administration of chemotherapy into vein, each additional hour68$22$61
Electronic analysis of implanted brain, spinal cord, or peripheral neurostimulator generator65$14$43
Complete blood count (CBC) with differential53$8$26
Folic acid level test52$14$57
Injection of additional new drug or substance into vein51$12$58
Nerve conduction, 3-4 studies47$77$263
Liver function blood test panel31$8$50
Administration of chemotherapy into vein, 1 hour or less30$79$290
Injection, diphenhydramine hcl, up to 50 mg28$1$20
Electronic analysis of implanted brain, spinal cord, or peripheral neurostimulator generator with brain stimulator programming, first 15 minutes with qualified health professional26$39$112
Injection, methylprednisolone sodium succinate, up to 125 mg26$4$30
Electronic analysis of implanted brain, spinal cord, or peripheral neurostimulator generator with brain stimulator programming, each additional 15 minutes with qualified health professional23$34$97
Comprehensive metabolic blood panel22$10$50
Thyroid stimulating hormone (TSH) test16$16$37
Measurement of brain wave activity (eeg), 41-60 minutes15$266$702
Vitamin D level test14$29$45
Free thyroxine (T4) test14$8$68
New patient office visit, complex (60-74 min)13$164$445
Measurement of brain wave activity (eeg), awake and drowsy12$36$620
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
0.4% high complexity
96.5% medium
3.1% routine

Industry Payment Transparency

Open Payments through 2024 ↗
$644,874
Total received (2018-2024)
Avg $92,125/year across 7 years
Top 1% in TX for neurology
64
Companies
1,745
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$619,441 (96.1%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$13,730 (2.1%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$11,703 (1.8%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$48,832
2023
$69,045
2022
$92,121
2021
$70,600
2020
$95,394
2019
$136,990
2018
$131,892

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Biogen, Inc.
$420,744
Alexion Pharmaceuticals, Inc.
$149,032
ABBVIE INC.
$24,610
Celgene Corporation
$21,688
E.R. Squibb & Sons, L.L.C.
$8,909
Kyowa Kirin, Inc.
$5,229
Teva Pharmaceuticals USA, Inc.
$4,520
Medtronic, Inc.
$1,069
Novartis Pharmaceuticals Corporation
$815
Boston Scientific Corporation
$755
Supernus Pharmaceuticals, Inc.
$552
EMD Serono, Inc.
$531
GENZYME CORPORATION
$454
Neurocrine Biosciences, Inc.
$402
Amgen Inc.
$367
Abbott Laboratories
$365
PFIZER INC.
$350
UCB, Inc.
$323
Genentech USA, Inc.
$323
US WorldMeds, LLC
$271
Allergan Inc.
$256
REVANCE THERAPEUTICS, INC.
$207
Allergan, Inc.
$202
Biohaven Pharmaceutical Holding Company Ltd.
$196
Avanir Pharmaceuticals, Inc.
$194
AbbVie Inc.
$162
SK Life Science, Inc.
$147
Medtronic USA, Inc.
$136
Jazz Pharmaceuticals Inc.
$131
Takeda Pharmaceuticals U.S.A., Inc.
$128
Axsome Therapeutics, Inc.
$127
AbbVie, Inc.
$126
Biohaven Pharmaceuticals, Inc.
$125
ARGENX US, INC.
$114
Eisai Inc.
$110
Amneal Pharmaceuticals LLC
$109
ANI Pharmaceuticals, Inc.
$104
Akcea Therapeutics, Inc.
$98
Horizon Therapeutics plc
$96
Harmony Biosciences LLC
$86
Lilly USA, LLC
$84
JAZZ PHARMACEUTICALS INC.
$83
ACADIA Pharmaceuticals Inc
$50
Promius Pharma LLC
$48
Bayer HealthCare Pharmaceuticals Inc.
$40
Greenwich Biosciences, Inc.
$39
Acorda Therapeutics, Inc
$36
CSL Behring
$34
Novo Nordisk Inc
$33
Ipsen Biopharmaceuticals, Inc
$31
Lundbeck LLC
$29
Merz Pharmaceuticals, LLC
$24
Mylan Institutional Inc.
$20
TG Therapeutics, Inc.
$20
TG THERAPEUTICS, INC.
$18
Exeltis, USA Inc.
$17
Regeneron Healthcare Solutions, Inc.
$17
Otsuka America Pharmaceutical, Inc.
$15
Nestle HealthCare Nutrition Inc.
$13
Mallinckrodt LLC
$13
Intercept Pharmaceuticals, Inc.
$12
IMPEL PHARMACEUTICALS INC.
$12
Impax Laboratories, Inc.
$12
Janssen Biotech, Inc.
$12
Top 3 companies account for 92.2% of total payments
Associated products mentioned in payments ›
ACTHAR · ADUHELM · AIMOVIG · AJOVY · APOKYN · AUBAGIO · AUSTEDO · Actemra · Aimovig · Austedo XR · Auvelity · BOTOX · BOTOX THERAPEUTIC · BRIUMVI · Betaseron · Briviact · COPAXONE · CREXONT · DAXXIFY · DUOPA · DUPIXENT · DYSPORT · Dexilant · Duopa · EMGALITY · ENTYVIO · EPIDIOLEX · EVENITY · Enspryng · Epidiolex · Fintepla · GILENYA · Hizentra · Hulio · INBRIJA · INFINITY · INGREZZA · INTELLIS ADAPTIVESTIM · Infinity DBS Pulse Generators · KESIMPTA · KISUNLA · Kerendia · LEMTRADA · Leqembi · MAVENCLAD · MAYZENT · MYOBLOC · Mavenclad · NAMZARIC · NOURIANZ · NUEDEXTA · NUPLAZID · NURTEC ODT · Nayzilam · Nourianz · Nuedexta · OCALIVA · OCREVUS · OCTAGAM IMMUNE GLOBULIN (HUMAN) · ONGENTYS · ONGENTYS 50MG CAPSULES 30 · ONZETRA Xsail · OSTEOCOOL RF ABLATION · OXTELLAR XR · Ocrevus · Ongentys · Ozanimod · PERCEPT PC BRAINSENSE · PROCLAIM · PURIFIED CORTROPHIN GEL · QALSODY · QULIPTA · REXULTI · RINVOQ · RYTARY · Rebif · Rystiggo · SOLIRIS · SPINRAZA · STELARA · Soliris · TECFIDERA · TEGSEDI · TRINTELLIX · TROKENDI XR · TYSABRI · Trintellix · Trudhesa · Tysabri · UBRELVY · ULTOMIRIS · UPLIZNA · VRAYLAR · VUMERITY · VYVGART · VYVGART HYTRULO · Vercise · Victoza · Vimpat · Wakix · XCOPRI · Xadago · Xeomin · ZEMBRACE SYMTOUCH · ZENPEP · ZEPOSIA · Zembrace · Zinbryta
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

The majority of payments (96%) are for speaking programs and promotional activities, which reflect participation in industry-sponsored educational or marketing events. This is common in neurology and does not inherently indicate bias, but patients may wish to be aware. Total industry engagement is in the top 1% for neurology in TX.

Equivalent to $805 per 100 Medicare services performed
Looking for a neurology in Amarillo?
Compare neurologys in the Amarillo area by procedure volume, costs, and industry payment transparency.
Browse neurologys nearby

Geographic Context

Neurologys within 10 mi
8
Per 100K population
6.9
County median income
$50,448
Nearest hospital
NORTHWEST TEXAS HOSPITAL
0.0 mi

Data Sources

Provider Registry NPPESWeekly updates
Medicare Enrollment PECOSMonthly updates
Practice Data Medicare Util.Annual (CY lag)
Industry Payments Open PaymentsCY 2024
Disciplinary History— Not publicN/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →

Summary

Dr. Milligan is a mixed practice specialist, with above-average Medicare volume (top 1% in TX), and high industry engagement (speaking/promotional, top 1%), with 19 years of practice experience.

This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →

Frequently Asked Questions

Is Dr. Milligan experienced with injection, natalizumab, 1 mg?
Based on Medicare claims data, Dr. Milligan performed 46,201 injection, natalizumab, 1 mg services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Milligan receive payments from pharmaceutical companies?
Yes. Dr. Milligan received a total of $644,874 from 64 companies across 1,745 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Milligan's costs compare to other neurologys in Amarillo?
Dr. Milligan's average Medicare payment per service is $15. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Milligan) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →